Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Otsuka

Status: Completed

Conditions: Autism

Treatments: Drug: Aripiprazole oral product

Study type: Observational

Funder types: Industry

Identifiers

NCT03179787

031-101-00116

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and effectiveness of aripiprazole in patients with autism in the real world clinical setting in Japan.

Enrollment: 528 patients

Sex: All

Ages: 6 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosed as autism with irritability

Exclusion criteria

• patients who has ever been treated with aripiprazole

Trial design